Finance

Lists
Why is BHVN down 4,29%?
Dive Deeper
BHVN:NYSE
Biohaven Ltd
10,93 USD
-4,29%
(-0,49) 1D
10,84 USD
-0,82% (-0,090)
After hours
Closed: 14-окт., 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHVN...
Open
11,39 USD
High
11,50 USD
Low
10,82 USD
Mkt. cap
1,65 млд
Avg. vol.
2,74 млн
Volume
0,00
52-wk high
18,57 USD
52-wk low
7,48 USD
EPS
-4,64 USD
Beta
3,19
Shares outstanding
151,04 млн
No. of employees
274
Open
11,39 USD
High
11,50 USD
Low
10,82 USD
Mkt. cap
1,65 млд
Avg. vol.
2,74 млн
Volume
0,00
52-wk high
18,57 USD
52-wk low
7,48 USD
EPS
-4,64 USD
Beta
3,19
Shares outstanding
151,04 млн
No. of employees
274
News stories
From web sources and news partners
About Biohaven Ltd
CEO-
Employees274
Founded2022
HeadquartersНью Хейвен, Коннектикут, Америка Кошмо Штаттары
Sector-
Websitebiohaven.com
Analyst ratings
Based on 11 analysts giving stock ratings to BHVN in the past 3 months
Buy
Buy
7
Hold
3
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for BHVN in the last 3 months.
Highest
Current 10,93 USD
30,00 USD (+174,47%)
Average
19,63 USD (+79,60%)
Lowest
10,00 USD (-8,51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dina Ramadane
Bank of America Securities
Sell
Maintained
11,00 USD
+0,6%
10/12/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
21,00 USD
+92,1%
10/09/2026
Samantha Semenkow
Citi
Buy
Maintained
17,00 USD
+55,5%
09/17/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
09/13/2026
Douglas Tsao
H.C. Wainwright
Hold
Maintained
10,00 USD
-8,5%
09/10/2026
Christopher Raymond
Raymond James
Buy
Maintained
-
-
09/10/2026
Myles Minter
William Blair
Hold
Reiterated
-
-
09/09/2026
Leonid Timashev
RBC Capital
Hold
Downgraded
19,00 USD
+73,8%
09/08/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
30,00 USD
+174,5%
08/17/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
19,00 USD
+73,8%
08/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
30,00 USD
+174,5%
08/11/2026
David Hoang
Deutsche Bank
Buy
Reiterated
20,00 USD
+83%
06/26/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
25,00 USD
+128,7%
05/28/2026
Ashwani Verma
UBS
Hold
Reiterated
11,00 USD
+0,6%
05/28/2026
Unknown Analyst
Bernstein
Hold
Maintained
9,00 USD
-17,7%
05/13/2026
Last report
2026-ж., 10-авг.
Fiscal period
Q2 2026
-0,78 USD / -0,61 USD
-27,61%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
141,17 млн
84,93 млн
103,83 млн
100,81 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,21 млн
20,79 млн
26,60 млн
24,08 млн
Operating expense
169,38 млн
105,72 млн
130,43 млн
124,90 млн
Total operating expenses
169,38 млн
105,72 млн
130,43 млн
124,90 млн
Operating income
-169,38 млн
-105,72 млн
-130,43 млн
-124,90 млн
Other non operating income
-7,25 млн
-5,29 млн
-3,08 млн
-14,70 млн
EBT including unusual items
-173,22 млн
-145,20 млн
-130,26 млн
-136,92 млн
EBT excluding unusual items
-176,63 млн
-111,01 млн
-133,51 млн
-139,60 млн
Income tax expense
221,00 миң
351,00 миң
272,00 миң
391,00 миң
Effective tax rate
-0,13%
-0,24%
-0,21%
-0,29%
Other operating expenses
-
-
-
-
Net income
-173,44 млн
-145,56 млн
-130,53 млн
-137,31 млн
Net profit margin
-
-
-
-
Earnings per share
-1,47
-0,90
-0,69
-0,78
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-166,26 млн
-103,15 млн
-128,06 млн
-122,64 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору